CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rise in support for pharma and biotech sectors
4.1.2. Increasing outsourcing efficacy testing
4.2. Market Restraints & Challenges
4.2.1. The rise in the competition among the key players
4.3. Market Opportunities
4.3.1. Emerging markets
CHAPTER 5. GLOBAL EFFICACY TESTING MARKET– BY TYPE
5.1. Introduction
5.2. Antimicrobial/Preservative Efficacy Testing
5.3. Disinfectant Efficacy Testing
CHAPTER 6. GLOBAL EFFICACY TESTING MARKET– BY PRODUCTS &
SERVICES
6.1. Introduction
6.2. Consumables
6.3. Instruments
6.4. Services
CHAPTER 7. GLOBAL EFFICACY TESTING MARKET– BY APPLICATION
7.1. Introduction
7.2. Pharmaceutical Manufacturing
7.3. Cosmetics and Personal Care Products
7.4. Medical Devices
CHAPTER 8. GLOBAL EFFICACY TESTING MARKET- BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL EFFICACY TESTING MARKET- COMPANY PROFILES
9.1. Charles River
9.2. Biomérieux Sa
9.3. SGS
9.4. North American Science Associates
9.5. Wuxi Apptec
9.6. Merck KGaA
9.7. Pacific Biolabs
9.8. Becton Dickinson and Company
9.9. Eurofins Scientific
9.10. American Type Culture Collection
9.11. Toxikon Corporation
CHAPTER 10. GLOBAL EFFICACY TESTING MARKET- COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
